Khaled Mahmoud

969 total citations
49 papers, 739 citations indexed

About

Khaled Mahmoud is a scholar working on Rheumatology, Transplantation and Surgery. According to data from OpenAlex, Khaled Mahmoud has authored 49 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 12 papers in Transplantation and 9 papers in Surgery. Recurrent topics in Khaled Mahmoud's work include Renal Transplantation Outcomes and Treatments (12 papers), Systemic Lupus Erythematosus Research (12 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). Khaled Mahmoud is often cited by papers focused on Renal Transplantation Outcomes and Treatments (12 papers), Systemic Lupus Erythematosus Research (12 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). Khaled Mahmoud collaborates with scholars based in Egypt, United Kingdom and Germany. Khaled Mahmoud's co-authors include Alaa Sabry, Hamdy Abo-Zenah, Hussein Sheashaa, Amr El‐Husseini, Mohamed A. Ghoneim, Mohamed Sobh, Gerhard Opelz, Edward M Vital, A. Abdel-Khalek and S GEORGE and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Fertility and Sterility.

In The Last Decade

Khaled Mahmoud

47 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khaled Mahmoud Egypt 17 238 190 172 147 137 49 739
Leïla Tricot France 15 72 0.3× 98 0.5× 233 1.4× 110 0.7× 126 0.9× 19 750
Antonij Slavčev Czechia 19 66 0.3× 333 1.8× 351 2.0× 138 0.9× 327 2.4× 75 1.0k
Myoung Hee Park South Korea 21 157 0.7× 452 2.4× 88 0.5× 181 1.2× 131 1.0× 83 1.2k
Can Öztürk Türkiye 19 71 0.3× 89 0.5× 159 0.9× 247 1.7× 285 2.1× 68 1.0k
M. Carrera Spain 19 91 0.4× 96 0.5× 505 2.9× 131 0.9× 385 2.8× 53 1.2k
P Royer United States 11 82 0.3× 274 1.4× 63 0.4× 31 0.2× 65 0.5× 37 616
Jennifer A. Cheeseman United States 13 36 0.2× 217 1.1× 466 2.7× 214 1.5× 348 2.5× 23 851
Farhad Heshmati France 15 45 0.2× 513 2.7× 50 0.3× 136 0.9× 89 0.6× 45 922
Larissa Kerecuk United Kingdom 13 29 0.1× 101 0.5× 50 0.3× 80 0.5× 93 0.7× 25 741
Ashima Gulati India 21 87 0.4× 218 1.1× 88 0.5× 65 0.4× 128 0.9× 45 1.4k

Countries citing papers authored by Khaled Mahmoud

Since Specialization
Citations

This map shows the geographic impact of Khaled Mahmoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled Mahmoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled Mahmoud more than expected).

Fields of papers citing papers by Khaled Mahmoud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled Mahmoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled Mahmoud. The network helps show where Khaled Mahmoud may publish in the future.

Co-authorship network of co-authors of Khaled Mahmoud

This figure shows the co-authorship network connecting the top 25 collaborators of Khaled Mahmoud. A scholar is included among the top collaborators of Khaled Mahmoud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khaled Mahmoud. Khaled Mahmoud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahmoud, Khaled, Michelle Wilson, Md Yuzaiful Md Yusof, et al.. (2024). O14 Rituximab objective outcome measures trial in SLE (ROOTS): outcomes of randomised and rescue rituximab therapy in a double-blind randomised placebo-controlled trial. SHILAP Revista de lepidopterología. A16.2–A17.
2.
Mahmoud, Khaled, Md Yuzaiful Md Yusof, Lee Suan Teh, et al.. (2024). Improving the arthritis component of the SLEDAI-2K. Lara D. Veeken. 64(6). 3556–3562. 1 indexed citations
3.
Sandler, Robert D, Edward M Vital, Khaled Mahmoud, et al.. (2023). Revision to the musculoskeletal domain of the BILAG-2004 index to incorporate ultrasound findings. Lara D. Veeken. 63(2). 498–505. 5 indexed citations
4.
Mahfouz, Ahmed, et al.. (2023). Appropriateness and clinical outcomes of short sustained low-efficiency dialysis: A national experience. Open Medicine. 18(1). 20230868–20230868.
5.
6.
Mahmoud, Khaled, Ahmed S Zayat, Md Yuzaiful Md Yusof, et al.. (2018). Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus. Lara D. Veeken. 58(8). 1353–1360. 10 indexed citations
7.
Mahmoud, Khaled, et al.. (2016). FRI0315 A Prospective Study To Assess Responsiveness of Clinical and Ultrasound Outcome Measures for Musculoskeletal Sle. Annals of the Rheumatic Diseases. 75. 549–549. 1 indexed citations
8.
Sheashaa, Hussein, Ahmed Lotfy, Azza Abdel‐Aziz, et al.. (2016). Protective effect of adipose-derived mesenchymal stem cells against acute kidney injury induced by ischemia-reperfusion in Sprague-Dawley rats. Experimental and Therapeutic Medicine. 11(5). 1573–1580. 40 indexed citations
9.
Cole, Laura M., Khaled Mahmoud, Sarah Haywood‐Small, et al.. (2013). Recombinant " IMS TAG" proteins – A new method for validating bottom‐up matrix‐assisted laser desorption/ionisation ion mobility separation mass spectrometry imaging. Rapid Communications in Mass Spectrometry. 27(21). 2355–2362. 19 indexed citations
10.
Mahmoud, Khaled, et al.. (2012). Norepinephrine supplemented with dobutamine or epinephrine for the cardiovascular support of patients with septic shock. Indian Journal of Critical Care Medicine. 16(2). 75–80. 27 indexed citations
11.
Refaie, Ayman, Khaled Mahmoud, M. Ismail, et al.. (2011). Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant.. PubMed. 9(5). 295–301. 7 indexed citations
12.
13.
Sabry, Alaa, Hamdy Abo-Zenah, Ehab W. Wafa, et al.. (2010). Sleep disorders in hemodialysis patients.. PubMed. 21(2). 300–5. 44 indexed citations
14.
Mahmoud, Khaled, et al.. (2009). Nail changes in kidney transplant recipients. Nephrology Dialysis Transplantation. 25(1). 274–277. 20 indexed citations
15.
Gheith, Osama, Ehab W. Wafa, Nabil Hassan, et al.. (2009). Does posttransplant anemia at 6 months affect long-term outcome of live-donor kidney transplantation? A single-center experience. Clinical and Experimental Nephrology. 13(4). 361–366. 28 indexed citations
16.
El‐Agroudy, Amgad E., et al.. (2008). Long-term graft outcome in patients with chronic allograft dysfunction after immunosuppression modifications.. PubMed. 13(4). 46–54. 2 indexed citations
17.
Sheashaa, Hussein, Mohamed A. Bakr, M. Ismail, et al.. (2008). Basiliximab induction therapy for live donor kidney transplantation: a long-term follow-up of prospective randomized controlled study. Clinical and Experimental Nephrology. 12(5). 376–381. 19 indexed citations
18.
19.
Sabry, Alaa, et al.. (2007). Correlation between levels of TNF-α and IL-6 and hematological involvement in SLE Egyptian Patients with lupus nephritis. International Urology and Nephrology. 38(3-4). 731–737. 34 indexed citations
20.
Sabry, Alaa, Hussein Sheashaa, Amr El‐Husseini, et al.. (2006). Proinflammatory cytokines (TNF-α and IL-6) in Egyptian patients with SLE: Its correlation with disease activity. Cytokine. 35(3-4). 148–153. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leïla Tricot Breakdown of academic impact, for papers by Antonij Slavčev Breakdown of academic impact, for papers by Myoung Hee Park Breakdown of academic impact, for papers by Can Öztürk Breakdown of academic impact, for papers by M. Carrera Breakdown of academic impact, for papers by P Royer Breakdown of academic impact, for papers by Jennifer A. Cheeseman Breakdown of academic impact, for papers by Farhad Heshmati Breakdown of academic impact, for papers by Larissa Kerecuk Breakdown of academic impact, for papers by Ashima Gulati
Rankless by CCL
2026